US Pharma MarketingEuropean drug manufacturers under threat from proposed US supply chain bill
European drug manufacturers under threat from proposed US supply chain bill is a pharma and life sciences industry update from Pharmaceutical Technology. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
US efforts to scrutinise overseas drug manufacturing could expose Europe’s role in supplying FDA-approved innovator and biosimilar drugs.
Source: Pharmaceutical Technology